Learn how to identify RSV symptoms in adults, how to know if an RSV infection has become serious, how to avoid RSV, and whether to get an RSV vaccine.

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually experience RSV as a mild cold, infants can develop more severe conditions, ...

Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

"Our findings highlight how multimorbidity is associated with more severe RSV outcomes, and support RSV vaccination for eligible high-risk patients with multiple underlying conditions." — Kevin Ma, ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

How effective is nirsevimab at preventing respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD), ...